MarketInOut Stock Screener Log In | Sign Up

Fangzhou Inc

HKSE • Healthcare • Pharmaceutical Retailers • Quote as of 10/30/2026
Fangzhou Inc stock price and volume chart

Company Profile

IndustryPharmaceutical Retailers
SectorHealthcare
ExchangeHKSE
Market Capitalization1,246.9 mln
Float624 mln
Earnings Date03/19/2027

EPS

0.01
Overpriced

P / E

100
Highly speculative

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-1.74
Likely manipulated

1-Year Forecast

6.04
Transformational upside

Relative Strength

97 / 100
Top performer

Business Description

Founded in 2015 and headquartered in Guangzhou, China, Fangzhou Inc. helps patients manage long-term health conditions such as heart disease, high blood pressure, and respiratory illness through its online platform. The company sells medications and health products through its own website, third-party platforms, and physical pharmacy locations. It also connects patients with doctors for online consultations and prescriptions, and supplies pharmaceutical products to other businesses in bulk.

Key Fundamentals

EPS0.01
P/E100
ROE4.18
RPS3.30
ROIC10.12
ROA0.99
Interest Cover10.09
EBITDA, mln27.40
EV / EBITDA22.19
EV / EBIT105
Revenue, mln4,305
EV / Revenue0.14

Quote Details

Last 1.00
Change -0.01 (-0.99%)
Open 1.01
Volume 180,000
Turnover 180,000
Average Volume 337,170

Financial Ratios

Pre-Tax Profit Margin0
Leverage Ratio3.29
Current Ratio1.40
Price / Book3.40
Price / Tangible Book3.40
Price / Cash Flow18.02
Price / Free Cash Flow18.88
Debt / Equity0.08
Price / Sales0.27

Financial Strength

Altman Z-Score1.97
Piotroski F-Score 6 / 9
Beneish M-Score-1.74
Price to Graham Number3.54
1-Year Target Price6.04

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 11.11% 95 / 100   
1 Month 21.21% 96 / 100   
2 Months 35.14% 94 / 100   
6 Months -21.87% 43 / 100   
1 Year -72.97% 6 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog